Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $430.45 million. The enterprise value is $252.12 million.

Market Cap	430.45M
Enterprise Value	252.12M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

LXEO has 74.09 million shares outstanding. The number of shares has increased by 68.76% in one year.

Current Share Class	74.09M
Shares Outstanding	74.09M
Shares Change (YoY)	+68.76%
Shares Change (QoQ)	+25.21%
Owned by Insiders (%)	0.25%
Owned by Institutions (%)	75.00%
Float	41.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	1.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.21, with a Debt / Equity ratio of 0.03.

Current Ratio	11.21
Quick Ratio	10.81
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,150.07

Financial Efficiency

Return on equity (ROE) is -55.00% and return on invested capital (ROIC) is -35.82%.

Return on Equity (ROE)	-55.00%
Return on Assets (ROA)	-32.86%
Return on Invested Capital (ROIC)	-35.82%
Return on Capital Employed (ROCE)	-43.38%
Weighted Average Cost of Capital (WACC)	15.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.69M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.15% in the last 52 weeks. The beta is 2.01, so LXEO's price volatility has been higher than the market average.

Beta (5Y)	2.01
52-Week Price Change	+58.15%
50-Day Moving Average	6.32
200-Day Moving Average	7.04
Relative Strength Index (RSI)	43.19
Average Volume (20 Days)	1,059,563

Short Selling Information

The latest short interest is 12.60 million, so 17.01% of the outstanding shares have been sold short.

Short Interest	12.60M
Short Previous Month	12.50M
Short % of Shares Out	17.01%
Short % of Float	30.42%
Short Ratio (days to cover)	11.79

Income Statement

Revenue	n/a
Gross Profit	-63.80M
Operating Income	-109.26M
Pretax Income	-99.96M
Net Income	-99.96M
EBITDA	-108.67M
EBIT	-109.26M
Earnings Per Share (EPS)	-$1.86

Full Income Statement

Balance Sheet

The company has $181.77 million in cash and $7.89 million in debt, giving a net cash position of $173.88 million or $2.35 per share.

Cash & Cash Equivalents	181.77M
Total Debt	7.89M
Net Cash	173.88M
Net Cash Per Share	$2.35
Equity (Book Value)	246.67M
Book Value Per Share	3.38
Working Capital	171.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$98.56 million and capital expenditures -$397,000, giving a free cash flow of -$98.96 million.

Operating Cash Flow	-98.56M
Capital Expenditures	-397,000
Depreciation & Amortization	588,000
Net Borrowing	-533,000
Free Cash Flow	-98.96M
FCF Per Share	-$1.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-68.76%
Shareholder Yield	-68.76%
Earnings Yield	-23.46%
FCF Yield	-23.23%

Analyst Forecast

The average price target for LXEO is $18.44, which is 217.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.44
Price Target Difference	217.38%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2